a month ago
COO
AnalystsRobbie MarcusRobbie Marcus's Stock Forecasts
AnalystsRobbie Marcus
Analyst Ranking
Top 16%
#735 out of 4555 analysts
Average Return
+7.87%
Win Rate
53%31 out of 59
Risk vs Reward
Poor
Good
Robbie Marcus's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rxsight IncRXST | +252.49% | $15.24 | $53.72 | 2023-03-06 - 2024-03-06 | Strong Buy |
Conmed CorpCNMD | +102.61% | $65.64 | $132.99 | 2020-04-22 - 2021-04-23 | Strong Buy |
Neuropace IncNPCE | +97.74% | $7.07 | $13.98 | 2023-11-06 - 2024-04-19 | Strong Buy |
Inspire Medical Systems IncINSP | +94.81% | $128.00 | $249.36 | 2020-09-21 - 2021-09-20 | Strong Buy |
Minerva Surgical IncUTRS | +89.87% | $47.00 | $4.77 | 2022-08-09 - 2023-08-09 | Strong Sell |
Robbie Marcus Analyst Color
Get additional color on Robbie Marcus's coverage of popular stocks
a year ago
SYK
a year ago
ISRG
a year ago
PEN
Robbie Marcus's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cooper Companies IncCOO | 3 | Strong Buy | $120.00 | +32.71% | Upgrades | a month ago |
Neuropace IncNPCE | 3 | Strong Buy | $17.00 | +21.60% | Maintains | a month ago |
Silk Road Medical IncSILK | 2 | Hold | $19.00 | +9.70% | Maintains | 2 months ago |
Rxsight IncRXST | 3 | Strong Buy | $62.00 | +20.20% | Maintains | 2 months ago |
Insulet CorpPODD | 3 | Strong Buy | $225.00 | +35.34% | Maintains | 2 months ago |
Penumbra IncPEN | 4 | Hold | $250.00 | +23.32% | Downgrades | 2 months ago |
Zimmer Biomet Holdings IncZBH | 3 | Hold | $125.00 | +4.66% | Maintains | 2 months ago |
Baxter International IncBAX | 6 | Hold | $44.00 | +11.48% | Maintains | 2 months ago |
Conmed CorpCNMD | 3 | Strong Buy | $115.00 | +58.31% | Maintains | 3 months ago |
Boston Scientific CorpBSX | 3 | Strong Buy | $72.00 | +6.94% | Maintains | 3 months ago |
Cvrx IncCVRX | 4 | Strong Buy | $36.00 | +141.61% | Maintains | 3 months ago |
Zimvie IncZIMV | 3 | Hold | $16.00 | +3.69% | Maintains | 4 months ago |
Inogen IncINGN | 5 | Strong Sell | $7.00 | +3.70% | Maintains | 5 months ago |
Nevro CorpNVRO | 4 | Hold | $18.00 | +49.13% | Maintains | 6 months ago |
Atricure IncATRC | 2 | Strong Buy | $50.00 | +115.52% | Maintains | 6 months ago |
Inspire Medical Systems IncINSP | 4 | Strong Buy | $181.00 | -21.04% | Maintains | 6 months ago |
Edwards Lifesciences CorpEW | 2 | Strong Buy | $100.00 | +16.36% | Maintains | 9 months ago |
Intuitive Surgical IncISRG | 3 | Strong Buy | $365.00 | -0.37% | Maintains | 9 months ago |
Integra Lifesciences Holdings CorpIART | 4 | Strong Sell | $43.00 | +49.93% | Downgrades | a year ago |
Stryker CorpSYK | 3 | Strong Buy | $315.00 | -3.20% | Maintains | a year ago |
Bausch & Lomb CorpBLCO | 2 | Hold | $17.00 | N/A | Maintains | a year ago |
Bioventus IncBVS | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Abbott LaboratoriesABT | 5 | Strong Buy | $118.00 | N/A | Maintains | a year ago |
Minerva Surgical IncUTRS | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Medtronic PLCMDT | 2 | Hold | $105.00 | N/A | Downgrades | 2 years ago |
Irhythm Technologies IncIRTC | 1 | Strong Buy | $116.00 | N/A | Upgrades | 2 years ago |
Acutus Medical IncAFIB | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Eargo IncEAR | 2 | Strong Sell | $220.00 | N/A | Downgrades | 3 years ago |
Smiledirectclub IncSDCCQ | 2 | Strong Sell | $6.00 | N/A | Downgrades | 3 years ago |
Treace Medical Concepts IncTMCI | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 3 years ago |
Glaukos CorpGKOS | 1 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.